October 17, 2025

Where Renal Cancer Strikes Hardest – and Why the Numbers Are Climbing Fast

Global analysis reveals sharp rises in incidence, survival gaps across regions, and key genetic risk factors shaping diagnostics

The Pathologist

October 17, 2025

Decentralized CAR-T: From Vision to Viability

What will it take to make decentralized CAR-T manufacturing work in the real world? Three experts discuss in this roundtable.

The Medicine Maker

October 15, 2025

Dana-Farber Research News 10.15.2025

This twice-monthly newsletter highlights recently published research where Dana-Farber faculty are listed as first or senior authors. The information is pulled from PubMed and this issue notes papers published from September 16 - September 30.

Dana-Farber

October 15, 2025

This Week’s Biopharma News: Regulatory Concerns at Novo Nordisk plant

This week’s news roundup reports on AstraZeneca's deal with the US government, the challenges of off-patent antibiotics, gene therapy for hearing loss, and more.

The Medicine Maker

October 14, 2025

Roswell Park Offers Exclusive CAR T-Cell Clinical Trial for Patients with Advanced or Metastatic Hepatoma

 A new, first-in-humans clinical trial for hepatocellular carcinoma uses an “armored” CAR T-cell therapy designed to resist the hostile tumor microenvironment found in 77% of patients with this disease.

Roswell Park Comprehensive Cancer Center

October 14, 2025

Surgical Resection With EGFR TKI Demonstrates Promising PFS in EGFR-Mutant NSCLC

Resection of the primary thoracic tumor after EGFR tyrosine kinase inhibition demonstrated the ability to prolong disease control in patients with EGFR-mutant metastatic non–small cell lung cancer (NS...

The ASCO Post

October 14, 2025

LDTs: The Hidden Engines of Precision Medicine

How LDTs give labs the agility to innovate beyond red tape – and deliver critical answers when patients need them most

The Pathologist

October 10, 2025

Seaport Criteria Bring Clarity to Myocarditis Grading

New guidelines combine hematoxylin and eosin and CD3 staining to improve diagnostic accuracy and reproducibility worldwide

The Pathologist

October 10, 2025

Prior Authorization Is Burdensome for Patients, Resulting in Treatment Delays, Financial Strain, and Stress

“This study makes clear what many of us in oncology have suspected: Prior authorization isn’t just an administrative hurdle for clinicians; it’s a hidden second job for patients,” noted investigators....

The ASCO Post